EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Cap 1 Red Fluorescent Reporter Gene

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA designed for high-efficiency red fluorescent protein expression in mammalian systems. The product features a Cap 1 structure and incorporates 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) to suppress innate immune activation and enhance mRNA stability (Guri-Lamce et al., 2024). This mRNA encodes monomeric mCherry, derived from Discosoma DsRed, and is provided at 1 mg/mL in 1 mM sodium citrate, pH 6.4. A poly(A) tail is present to further improve translation initiation, making it suitable for applications in cell localization and reporter gene assays. The product must be stored at or below -40°C to preserve activity.

Biological Rationale

Messenger RNA (mRNA) serves as the direct template for protein synthesis in eukaryotic cells. Exogenous mRNA delivery enables transient expression of proteins for research and therapeutic purposes (Guri-Lamce et al., 2024). mCherry is a red fluorescent protein (RFP) with excitation/emission maxima of 587 nm/610 nm, frequently used as a molecular marker for live-cell imaging, protein localization, and reporter gene assays (Product page). Cap 1 capping and nucleotide modifications are essential to mimic native mammalian mRNA, increase translation efficiency, and reduce innate immune recognition (EZ Cap™ mCherry mRNA: Cap 1 Reporter mRNA, 2024). The inclusion of a poly(A) tail further stabilizes the mRNA and enhances translation initiation (Red Fluorescent Reporter mRNA, 2024).

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

Cap 1 Structure: The mRNA features a Cap 1 structure at its 5′ end, enzymatically generated using Vaccinia virus capping enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2′-O-methyltransferase. This cap structure increases translation efficiency and stability by protecting the mRNA from exonucleases and facilitating ribosome recruitment (Next-Gen Reporter mRNA, 2024).
Modified Nucleotides: The incorporation of 5mCTP and ψUTP minimizes activation of cellular pattern recognition receptors (PRRs) such as TLR3, TLR7, TLR8, and RIG-I, which are responsible for detecting foreign RNA (Guri-Lamce et al., 2024).
Poly(A) Tail: The presence of a poly(A) tail enhances mRNA stability by preventing degradation and supports efficient translation initiation.
Translation: Once delivered into the cytoplasm, the mRNA is translated by host ribosomes into the mCherry protein, which emits red fluorescence suitable for live-cell imaging and molecular tracking (Applied Workflows with mCherry mRNA, 2024).

Evidence & Benchmarks

• Lipid nanoparticles (LNPs) effectively deliver exogenous mRNA, including base editor and reporter constructs, resulting in robust protein expression in vitro (Guri-Lamce et al., 2024, DOI).
• mRNA modifications with 5mCTP and ψUTP significantly reduce innate immune activation and cytokine induction compared to unmodified mRNA (Guri-Lamce et al., 2024).
• Cap 1-capped mRNA demonstrates higher translation efficiency in mammalian cells than Cap 0 or uncapped mRNA (Redefining Reporter Gene mRNA, 2024).
• mCherry protein encoded by this mRNA exhibits excitation/emission maxima at 587 nm/610 nm, providing a clear and stable red fluorescent signal for cell imaging (Product page).
• The mRNA length is approximately 996 nucleotides, optimized for efficient translation and delivery (Product page).

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is intended for use as a reporter gene in molecular and cell biology research. It is especially useful for:

• Fluorescent labeling of cells and subcellular components for imaging studies.
• Quantitative assays of transfection efficiency and gene expression.
• Tracking cell localization and migration in vitro and in vivo.
• Validating RNA delivery protocols and benchmarking new transfection reagents.

This article extends prior analyses by providing a structured, citation-rich summary of the product's mechanism and evidence base, building on EZ Cap™ mCherry mRNA: Cap 1 Reporter mRNA and clarifying technical limits not discussed in Red Fluorescent Reporter mRNA.

Common Pitfalls or Misconceptions

• Not suitable for stable genomic integration: This mRNA does not integrate into the host genome and only enables transient expression.
• Immune evasion is not absolute: Although 5mCTP and ψUTP suppress innate immune recognition, high-dose or repeated administrations may still trigger immune responses.
• Requires cold storage: The mRNA must be stored at or below -40°C; improper storage leads to rapid degradation.
• Not for direct therapeutic use: This product is intended for research only and is not validated for clinical applications.
• Expression depends on delivery method: Inefficient delivery (e.g., poor transfection) will limit detectable fluorescence.

Workflow Integration & Parameters

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4. It can be delivered to cells using lipid nanoparticles (LNPs), electroporation, or advanced transfection reagents optimized for mRNA. For optimal results, keep the mRNA on ice during experimental setup. Typical working concentrations range from 0.1 to 1 μg per well in a 24-well plate, depending on cell type and application. Fluorescence can be detected 4–24 hours post-transfection, with signal persistence up to 48–72 hours in many mammalian cell lines. For extended or in vivo studies, repeat dosing or co-transfection with stabilizing elements may be required (Applied Workflows with mCherry mRNA, 2024).

For further product specifications and support, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) combines advanced capping and nucleotide modification technologies to deliver robust, immune-evasive red fluorescent protein expression for cutting-edge molecular biology research. Its Cap 1 structure and inclusion of 5mCTP and ψUTP drive high translation efficiency and stability, supporting reliable cell labeling and localization studies. Ongoing advances in mRNA design and delivery are expected to further expand the utility of such reporter constructs in both basic and translational science.